Northwest Biotherapeutics secures funding
This article was originally published in Scrip
Executive Summary
Northwest Biotherapeuticshas sold a $700,000 equity stake to Al Rajhi Holdings to help support the US firm's working capital. Al Rajhi subscribed to one million new shares of the company's common stock at $0.70 per share.